Biosimilar Clinical Approach

By HEOR Staff Writer

June 23, 2025

What is the biosimilar clinical approach, and how is it changing biosimilar approvals in the EU? The biosimilar clinical approach—as outlined in the latest
Efficacy of Ultomiris Pediatric TMA Treatment
KEYTRUDA Head Neck Cancer Approval: Transforming Treatment and Health Economics
Mavyret Acute Hepatitis C: Pioneering Treatment Expansion and Economic Implic...
Advancements in HIV Vaccine Trials: Promising Results from mRNA Strategies
The Case for Transparency in Peer Review: Enhancing Scientific Integrity and ...
Enhertu Reimbursement Analysis: Navigating Cost-Effectiveness Challenges
Pluvicto Prostate Cancer Trial: Phase III Results
NICE’s Approval of Marstacimab for Hemophilia B: Transforming Treatment...
Alzheimer’s Blood Test Diagnostics: FDA Clears First Blood Test for Ear...
EMA AI Tool Qualification: How the AIM-NASH Approval Sets a Roadmap for Medic...
VIETNARMS Trial Unveils Innovative Hepatitis C Treatment Options
First At-Home HPV Testing Approval: FDA Clears Teal Wand